Danaher Corp chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 43.40
Dividend & Yield1.08$ (0.44%)
Beta 0.8
Market capitalization 184.43B
Operating cash flow 8.52B
ESG Scores 11.7

Company description

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Sector: Healthcare - Industry: Diagnostics & Research

Financial Ratios
Quick Ratio1.09
Working Capital1.83
Return On Equity0.15
Debt To Equity0.53
Fixed Asset Ratio0.3
Fixed Interest Cover34.32

Financial data

Financial Statements

Cashflow Statement 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Change To Liabilities -397M 745M 320M -554M
Total Cashflows From Investing Activities -1.24B -21.24B -12.99B -2.23B
Net Borrowings 13.35B -1.9B 2.06B -1.69B
Total Cash From Financing Activities 16.36B 1.01B 1.29B -2.57B
Change To Operating Activities 446M 221M 135M -2M
Issuance Of Stock 1.57B 1.88B 86M 31M
Net Income 3.01B 3.65B 6.43B 7.21B
Change In Cash 19.12B -13.88B -3.45B 3.41B
Effect Of Exchange Rate 45M 148M -115M -306M
Total Cash From Operating Activities 3.95B 6.21B 8.36B 8.52B
Depreciation 1.19B 1.77B 2.17B 2.22B
Change To Account Receivables -157M -264M -611M -477M
Other Cashflows From Financing Activities 369M -29M -112M -95M
Change To Netincome -115M 208M 415M 607M
Capital Expenditures -636M -791M -1.29B -1.15B

Income Statement 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Research Development 1.13B 1.35B 1.74B 1.75B
Income Before Tax 3.31B 4.5B 7.6B 8.29B
Net Income 3.01B 3.65B 6.43B 7.21B
Selling General Administrative 5.58B 6.88B 8.15B 8.46B
Gross Profit 9.98B 13.04B 18.06B 18.95B
Ebit 3.28B 4.82B 8.17B 8.74B
Operating Income 3.28B 4.82B 8.17B 8.74B
Interest Expense -108M -275M -238M -211M
Income Tax Expense 873M 849M 1.25B 1.08B
Total Revenue 17.91B 22.28B 29.45B 31.47B
Cost Of Revenue 7.93B 9.24B 11.4B 12.52B
Total Other Income ExpenseNet 24M -320M -570M -450M
Net Income From Continuing Ops 2.43B 3.65B 6.35B 7.21B
Net Income Applicable To Common Shares 2.94B 3.51B 6.27B 7.1B

Balance Sheet Statement 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Total Liabilities 31.8B 36.38B 38.01B 34.26B
Total Stockholder Equity 28.67B 36.5B 41.9B 48.41B
Other Current Liabilities 1.85B 3.49B 3.69B 3.67B
Total Assets 62.08B 76.16B 83.18B 84.35B
Common Stock 8M 9M 9M 9M
Other Current Assets 26M 6M 7M 6M
Retained Earnings 24.17B 27.16B 32.83B 39.2B
Treasury Stock -3.07B -368M -1.03B -2.87B
Cash 19.91B 6.04B 2.59B 6B
Total Current Liabilities 4.93B 7.4B 8.14B 8.39B
Other Stockholder Equity -3.07B -368M -1.03B -2.87B
Property, Plant, and Equipment 3.07B 4.2B 4.83B 4.96B
Total Current Assets 25.6B 13.8B 11.65B 15.88B
Net Tangible Assets -3.79B -20.2B -22.13B -11.64B
Net Receivables 3.46B 4.81B 5.52B 5.97B
Accounts Payable 1.51B 2.05B 2.57B 2.3B


Insider Transactions

Here are the insider transactions of stock shares related to Danaher Corp:

Filer Name Transaction Text Ownership Date Filer Relation Shares
GUTIERREZ-RAMOS JOSE-CARLOSStock Award(Grant) at price 0.00 per share.D2023-02-24Officer4.01k
HONEYCUTT JENNIFER LStock Award(Grant) at price 0.00 per share.D2023-02-24Officer7.03k
BOUDA CHRISTOPHERStock Award(Grant) at price 0.00 per share.D2023-02-24Officer1k
RASKAS DANIEL AStock Award(Grant) at price 0.00 per share.D2023-02-22Officer10.44k
WEIDEMANIS JOAKIMStock Award(Grant) at price 0.00 per share.D2023-02-22Officer26.39k
KING WILLIAM HStock Award(Grant) at price 0.00 per share.D2023-02-22Officer10.44k
ELLIS BRIAN WStock Award(Grant) at price 0.00 per share.D2023-02-22General Counsel11.05k
BLAIR RAINER MStock Award(Grant) at price 0.00 per share.D2023-02-22Chief Executive Officer42.21k
MCGREW MATTHEWStock Award(Grant) at price 0.00 per share.D2023-02-22Chief Financial Officer20.87k
HONEYCUTT JENNIFER LStock Award(Grant) at price 0.00 per share.D2023-02-22Officer16.42k
STEVENS RAYMOND C. PH.D.Sale at price 264.22 - 264.33 per share.D2023-01-25Director8.41k
STEVENS RAYMOND C. PH.D.Conversion of Exercise of derivative security at price 83.28 - 131.05 per share.D2023-01-25Director8.41k
WEIDEMANIS JOAKIMSale at price 266.44 - 266.98 per share.D2022-11-28Officer9.51k
WEIDEMANIS JOAKIMConversion of Exercise of derivative security at price 57.90 per share.D2022-11-28Officer6.61k
RALES MITCHELL PStock Gift at price 0.00 per share.D2022-11-17Officer and Director15.52k
COUCHARA GEORGEANN F.Sale at price 271.61 - 271.62 per share.D2022-11-15Officer1.88k
MCGREW MATTHEWSale at price 274.37 - 274.96 per share.D2022-11-11Chief Financial Officer18.93k
MCGREW MATTHEWConversion of Exercise of derivative security at price 56.70 - 57.90 per share.D2022-11-11Chief Financial Officer18.93k
HONEYCUTT JENNIFER LSale at price 265.00 per share.D2022-11-10Officer8.21k
HONEYCUTT JENNIFER LConversion of Exercise of derivative security at price 65.83 per share.D2022-11-10Officer8.21k
RASKAS DANIEL AStock Gift at price 0.00 per share.D2022-11-04Officer412
SPOON ALAN GSale at price 252.93 per share.D2022-10-25Director500
SPOON ALAN GConversion of Exercise of derivative security at price 50.80 per share.D2022-10-25Director3.49k
BLAIR RAINER MSale at price 300.00 per share.D2022-08-15Chief Executive Officer25k
BLAIR RAINER MConversion of Exercise of derivative security at price 65.83 - 70.75 per share.D2022-08-15Chief Executive Officer25k
RALES STEVEN MStock Gift at price 0.00 per share.I2022-08-08Chairman of the Board1.29M
WEIDEMANIS JOAKIMSale at price 270.21 - 272.85 per share.D2022-07-25Officer12k
LOHR WALTER G JRSale at price 273.84 per share.D2022-07-22Director3.91k
LOHR WALTER G JRConversion of Exercise of derivative security at price 38.64 per share.D2022-07-22Director4.55k
DEWAN FEROZStock Award(Grant) at price 0.00 per share.D2022-07-15Director315
SCHWIETERS JOHN TConversion of Exercise of derivative security at price 38.64 per share.D2022-07-13Director4.55k
RALES MITCHELL PPurchase at price 247.89 per share.I2022-05-16Officer and Director200
LOHR WALTER G JRStock Award(Grant) at price 0.00 per share.D2022-05-13Director372
SPOON ALAN GStock Award(Grant) at price 0.00 per share.D2022-05-13Director372
SCHWIETERS JOHN TStock Award(Grant) at price 0.00 per share.D2022-05-13Director372
HEFNER FILLER LINDA PStock Award(Grant) at price 0.00 per share.D2022-05-13Director372
ZERHOUNI ELIAS AStock Award(Grant) at price 0.00 per share.D2022-05-13Director372
LIST-STOLL TERI L.Stock Award(Grant) at price 0.00 per share.D2022-05-13Director372
STEVENS RAYMOND C. PH.D.Stock Award(Grant) at price 0.00 per share.D2022-05-13Director372
MEGA JESSICA L M.D.Stock Award(Grant) at price 0.00 per share.D2022-05-13Director372
SABETI PARDIS CStock Award(Grant) at price 0.00 per share.D2022-05-13Director372
SANDERS A.SHANEStock Award(Grant) at price 0.00 per share.D2022-05-13Director372
WEIDEMANIS JOAKIMSale at price 255.74 per share.D2022-04-25Officer6.5k
HONEYCUTT JENNIFER LSale at price 278.64 per share.D2022-02-25Officer3.78k
GUTIERREZ-RAMOS JOSE-CARLOSStock Award(Grant) at price 0.00 per share.D2022-02-24Officer2.21k
BOUDA CHRISTOPHERStock Award(Grant) at price 0.00 per share.D2022-02-24Officer921
RASKAS DANIEL AStock Award(Grant) at price 0.00 per share.D2022-02-23Officer12.75k
LALOR ANGELA SStock Award(Grant) at price 0.00 per share.D2022-02-23Officer22.77k
WEIDEMANIS JOAKIMStock Award(Grant) at price 0.00 per share.D2022-02-23Officer36.42k
KING WILLIAM HStock Award(Grant) at price 0.00 per share.D2022-02-23Officer12.75k
ELLIS BRIAN WStock Award(Grant) at price 0.00 per share.D2022-02-23General Counsel15.94k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Danaher Corp. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Danaher Corp

Here is the result of two systematic investment strategies applied to Danaher Corp. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Danaher Corp

The following chart shows the equity curve of the two systematic investment strategies applied to Danaher Corp:

Danaher Corp automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 105.44% on the backtest period.

Performance at glance

Performance

105.44 %

Latent gain

2498.23 $

Invested capital

2369.27 $

Annualized return

25.47 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Danaher Corp

This is the result of two momentum investment strategies applied to Danaher Corp. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Danaher Corp

The following chart shows all the entries opened by the momentum investment system on Danaher Corp:

Danaher Corp momentum entries
  • The first momentum investment strategy would give 161.22% of return on Danaher Corp. That represents 8211.34$ of latent gain with 5093.16$ of employed capital.
  • The second momentum investment strategy would give 165.4% of return on Danaher Corp. That represents 5662.51$ of latent gain with 3423.49$ of employed capital.
Performance at glance (1Q Momentum)

Performance

161.22 %

Latent gain

8211.34 $

Invested capital

5093.16 $

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

165.4 %

Latent gain

5662.51 $

Invested capital

3423.49 $

Annualized return

45.19 %

Momentum equity curve on Danaher Corp

The following chart shows the equity curve of the two momentum strategies applied to Danaher Corp:

Danaher Corp momentum equity

Note: the dividends potentially given by Danaher Corp are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Danaher Corp

The following chart shows the employed capital evolution of the two momentum strategies on Danaher Corp since the beginning:

Danaher Corp

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Danaher Corp

Buy the dip entry openings on Danaher Corp

Danaher Corp

The performance achieved by the robo-advisor on Danaher Corp is 0%. That represents 0.0$ of latent gain with 0.0$ of employed capital. The following chart shows Danaher Corp stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Danaher Corp, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 $

Invested capital

0.0 $

Annualized return

0.0 %

Equity curve of the strategy applied to Danaher Corp

The following chart shows the result of the investment strategy applied to Danaher Corp:

Danaher Corp

Note: the dividends potentially given by Danaher Corp are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Danaher Corp

The following chart shows the employed capital evolution since the beginning of the investment strategy on Danaher Corp:

Danaher Corp

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Danaher Corp

In this section, I will compare the three previous investment strategies applied to Danaher Corp.

Equity curve comparison on Danaher Corp

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Danaher Corp investment strategy comparison

Employed capital comparison on Danaher Corp

Danaher Corp investment comparison

Performance comparison on Danaher Corp

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 105.44% 2498.23$ 2369.27$ 25.47%
Momentum 1 quarter 161.22% 8211.34$ 5093.16$ 41.34%
Momentum 2 quarters 165.4% 5662.51$ 3423.49$ 45.19%
Non-directional 0% 0.0$ 0.0$ 0.0%
Annualized return comparison

Automatic investment

25.47 %

Momentum 1Q

45.19 %

Momentum 2Q

45.19 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Danaher Corp:

Note: The algorithm computes the probability of correlation between Danaher Corp and the other stocks. There may be false positives or some missing correlated stocks. If the price of Danaher Corp does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Danaher Corp
Country United States
City Washington
Address 2200 Pennsylvania Avenue, NW
Phone 202 828 0850
Website www.danaher.com
FullTime employees 79000
Industry Diagnostics & Research
Sector Healthcare
Exchange XNYS
Ticker DHR
Market www.nyse.com

Danaher Corp ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 1.4
Peer Environment Performance 2.0330864197531
Environment Percentile unknown
Palm Oil no
Nuclear no
Fur Leather no
GMO no
Coal no
Pesticides no
Animal Testing yes

Social scores

Social ESG Factors Scores
Social Score 5.2
Peer Social Performance 14.299012345679
Social Percentile unknown
Highest Controversy 2
Peer Highest Controversy Performance 1.8780487804878
Adult no
Gambling no
Alcoholic no
Tobacco no
Catholic yes
Controversial Weapons no
Small Arms no
Military Contract no
Peer Count yes

Related Controversy: Operations IncidentsCustomer Incidents


Governance scores

Governance ESG Factors Scores
Governance Score 5.2
Peer Governance Performance 8.8141975308642
Governance Percentile unknown

ESG at glance
Total ESG Scores: 11.7
Environment Score: 1.4
Social Score: 5.2
Governance Score: 5.2

ESG Performance: UNDER_PERF

Peer Group: Pharmaceuticals

Peer Esg Score Performance: 25.306097560976

Rating Year: 2022

Rating Month: 8

Max Age: 86400

Percentile: 4